Pharma margins expected to remain stable in FY2021 despite challenges: ICRA
Abatement in the US pricing pressure and broad-based growth across markets lead to stable growth during H1 FY2020
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.